Cargando…

Clinical characteristics of COVID-19 in Osaka, Japan: Comparison of the first–third waves with the fourth wave

BACKGROUND: The fourth wave of COVID-19 in Osaka Prefecture, Japan, caused a medical crisis. Here, we aim to identify the risk factors for COVID-19 severity and compare patients between the first–third waves and the fourth wave. METHODS: We performed an observational retrospective study of COVID-19...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurahara, Yu, Kobayashi, Takehiko, Shintani, Sayoko, Matsuda, Yoshinobu, Tamiya, Akihiro, Sugawara, Reiko, Arai, Toru, Tachibana, Kazunobu, Okishio, Kyoichi, Matsui, Hideo, Tsuyuguchi, Kazunari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Respiratory Society. Published by Elsevier B.V. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429365/
https://www.ncbi.nlm.nih.gov/pubmed/34565716
http://dx.doi.org/10.1016/j.resinv.2021.08.005
_version_ 1783750515622936576
author Kurahara, Yu
Kobayashi, Takehiko
Shintani, Sayoko
Matsuda, Yoshinobu
Tamiya, Akihiro
Sugawara, Reiko
Arai, Toru
Tachibana, Kazunobu
Okishio, Kyoichi
Matsui, Hideo
Tsuyuguchi, Kazunari
author_facet Kurahara, Yu
Kobayashi, Takehiko
Shintani, Sayoko
Matsuda, Yoshinobu
Tamiya, Akihiro
Sugawara, Reiko
Arai, Toru
Tachibana, Kazunobu
Okishio, Kyoichi
Matsui, Hideo
Tsuyuguchi, Kazunari
author_sort Kurahara, Yu
collection PubMed
description BACKGROUND: The fourth wave of COVID-19 in Osaka Prefecture, Japan, caused a medical crisis. Here, we aim to identify the risk factors for COVID-19 severity and compare patients between the first–third waves and the fourth wave. METHODS: We performed an observational retrospective study of COVID-19 cases at the National Hospital Organization Kinki-Chuo Chest Medical Center. RESULTS: We identified 404 patients (median age: 71.0 years [interquartile range: 56.0–80.0]), of whom 199 (49.1%) had mild disease, 142 (35.2%) had moderate disease, and 63 (15.6%) had severe disease. The overall mortality rate was 5.4% (22/404). Based on multivariate logistic regression analysis, cardiovascular disease, fever, dyspnea, and several inflammatory biomarkers were independent risk factors for moderate to severe disease. For every 1 mg/dL increase in C-reactive protein, 10 IU/L increase in lactate dehydrogenase, and 100 ng/mL increase in ferritin, the risk for moderate to severe disease increased by 18.3%, 12.9%, and 8.9%, respectively. Overall disease severity in the fourth wave was higher than in the first–third waves. However, there was no significant difference in mortality. Because of a shortage of beds, four of the 28 severe patients (14.3%) in the fourth wave could not be transferred to the advanced hospital. CONCLUSIONS: Cardiovascular disease, fever, dyspnea, and several inflammatory biomarkers were risk factors for moderate to severe COVID-19 in our cohort. During the fourth wave, COVID-19 severity worsened, increasing the number of patients who could not be transferred to beds for severe cases, resulting in a medical crisis in Osaka.
format Online
Article
Text
id pubmed-8429365
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Japanese Respiratory Society. Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-84293652021-09-10 Clinical characteristics of COVID-19 in Osaka, Japan: Comparison of the first–third waves with the fourth wave Kurahara, Yu Kobayashi, Takehiko Shintani, Sayoko Matsuda, Yoshinobu Tamiya, Akihiro Sugawara, Reiko Arai, Toru Tachibana, Kazunobu Okishio, Kyoichi Matsui, Hideo Tsuyuguchi, Kazunari Respir Investig Original Article BACKGROUND: The fourth wave of COVID-19 in Osaka Prefecture, Japan, caused a medical crisis. Here, we aim to identify the risk factors for COVID-19 severity and compare patients between the first–third waves and the fourth wave. METHODS: We performed an observational retrospective study of COVID-19 cases at the National Hospital Organization Kinki-Chuo Chest Medical Center. RESULTS: We identified 404 patients (median age: 71.0 years [interquartile range: 56.0–80.0]), of whom 199 (49.1%) had mild disease, 142 (35.2%) had moderate disease, and 63 (15.6%) had severe disease. The overall mortality rate was 5.4% (22/404). Based on multivariate logistic regression analysis, cardiovascular disease, fever, dyspnea, and several inflammatory biomarkers were independent risk factors for moderate to severe disease. For every 1 mg/dL increase in C-reactive protein, 10 IU/L increase in lactate dehydrogenase, and 100 ng/mL increase in ferritin, the risk for moderate to severe disease increased by 18.3%, 12.9%, and 8.9%, respectively. Overall disease severity in the fourth wave was higher than in the first–third waves. However, there was no significant difference in mortality. Because of a shortage of beds, four of the 28 severe patients (14.3%) in the fourth wave could not be transferred to the advanced hospital. CONCLUSIONS: Cardiovascular disease, fever, dyspnea, and several inflammatory biomarkers were risk factors for moderate to severe COVID-19 in our cohort. During the fourth wave, COVID-19 severity worsened, increasing the number of patients who could not be transferred to beds for severe cases, resulting in a medical crisis in Osaka. The Japanese Respiratory Society. Published by Elsevier B.V. 2021-11 2021-09-10 /pmc/articles/PMC8429365/ /pubmed/34565716 http://dx.doi.org/10.1016/j.resinv.2021.08.005 Text en © 2021 The Japanese Respiratory Society. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Original Article
Kurahara, Yu
Kobayashi, Takehiko
Shintani, Sayoko
Matsuda, Yoshinobu
Tamiya, Akihiro
Sugawara, Reiko
Arai, Toru
Tachibana, Kazunobu
Okishio, Kyoichi
Matsui, Hideo
Tsuyuguchi, Kazunari
Clinical characteristics of COVID-19 in Osaka, Japan: Comparison of the first–third waves with the fourth wave
title Clinical characteristics of COVID-19 in Osaka, Japan: Comparison of the first–third waves with the fourth wave
title_full Clinical characteristics of COVID-19 in Osaka, Japan: Comparison of the first–third waves with the fourth wave
title_fullStr Clinical characteristics of COVID-19 in Osaka, Japan: Comparison of the first–third waves with the fourth wave
title_full_unstemmed Clinical characteristics of COVID-19 in Osaka, Japan: Comparison of the first–third waves with the fourth wave
title_short Clinical characteristics of COVID-19 in Osaka, Japan: Comparison of the first–third waves with the fourth wave
title_sort clinical characteristics of covid-19 in osaka, japan: comparison of the first–third waves with the fourth wave
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429365/
https://www.ncbi.nlm.nih.gov/pubmed/34565716
http://dx.doi.org/10.1016/j.resinv.2021.08.005
work_keys_str_mv AT kuraharayu clinicalcharacteristicsofcovid19inosakajapancomparisonofthefirstthirdwaveswiththefourthwave
AT kobayashitakehiko clinicalcharacteristicsofcovid19inosakajapancomparisonofthefirstthirdwaveswiththefourthwave
AT shintanisayoko clinicalcharacteristicsofcovid19inosakajapancomparisonofthefirstthirdwaveswiththefourthwave
AT matsudayoshinobu clinicalcharacteristicsofcovid19inosakajapancomparisonofthefirstthirdwaveswiththefourthwave
AT tamiyaakihiro clinicalcharacteristicsofcovid19inosakajapancomparisonofthefirstthirdwaveswiththefourthwave
AT sugawarareiko clinicalcharacteristicsofcovid19inosakajapancomparisonofthefirstthirdwaveswiththefourthwave
AT araitoru clinicalcharacteristicsofcovid19inosakajapancomparisonofthefirstthirdwaveswiththefourthwave
AT tachibanakazunobu clinicalcharacteristicsofcovid19inosakajapancomparisonofthefirstthirdwaveswiththefourthwave
AT okishiokyoichi clinicalcharacteristicsofcovid19inosakajapancomparisonofthefirstthirdwaveswiththefourthwave
AT matsuihideo clinicalcharacteristicsofcovid19inosakajapancomparisonofthefirstthirdwaveswiththefourthwave
AT tsuyuguchikazunari clinicalcharacteristicsofcovid19inosakajapancomparisonofthefirstthirdwaveswiththefourthwave